Examples of using Antithrombin in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
with congenital antithrombin deficiency in clinical risk situations is 20-25 IU/kg bodyweight.
Treatment should be initiated under the supervision of a physician experienced in the treatment of patients with congenital antithrombin deficiency.
Oncaspar are given at the same time, alterations in coagulation parameters(e.g. fall in fibrinogen and Antithrombin III deficiency,
keep blood in the vessels, and antithrombin III, which prevents blood clots from forming.
Frequent antithrombin activity assessments and dosing adjustments may be necessary when starting treatment and just after surgery.
For example, extracellular serpins regulate the proteolytic cascades central to blood clotting(antithrombin), the inflammatory
No information is available on the possible effects of antithrombin alfa on male and female fertility.
For example, after injury to the blood vessel wall, heparin is exposed, and antithrombin is activated to control the clotting response.
The antithrombin activity level should be maintained above 80% for the duration of the treatment, unless clinical particulars would indicate a different effective level.
Get her up to ICU… She still needs a heparin drip, antithrombin, and serial coags.
a more rapid increase in Protein C and antithrombin levels.
No antibodies to antithrombin alfa have been detected up to 90 days following treatment with ATryn.
Tests can also be performed to detect low coagulation/anticoagulant factor antithrombin(AT) and protein(C) activity.
specifically bound to antithrombin protein with a dose-dependant plasma concentration binding 98.6% to 97.0% in the concentration range from 0.5 to 2 mg/l.
The company that makes ATryn has provided the results of a study looking at the use of ATryn during childbirth in women with congenital antithrombin deficiency to the Agency, and will submit an application with the aim of adding treatment during childbirth to the medicine's marketing authorisation.
The active substance in ATryn, antithrombin alfa, is a copy of the natural blood protein antithrombin, which is produced by‘recombinant DNA technology': it is extracted from the milk
Patients who have congenital antithrombin deficiency have low blood antithrombin levels and are therefore at increased risk of having blood clots.
The risk of diminution of antithrombin levels by prolonged treatment with a non-fractionated heparin should be taken into account.
In a formal clinical trial employing serial Duplex ultrasound examinations, antithrombin alfa was shown to be effective in the prevention of thromboembolic events in fourteen congenital antithrombin deficient patients in clinical high risk situations.
Antithrombin alfa should therefore not be used in pregnant women.